Search

Your search keyword '"Krzanowski, Marcin"' showing total 283 results
Start Over Author "Krzanowski, Marcin"
283 results on '"Krzanowski, Marcin"'

6. Predicting acute kidney injury onset using a random forest algorithm using electronic medical records of COVID-19 patients: the CRACoV-AKI model

Author

Krzanowska, Katarzyna, primary, Batko, Krzysztof, additional, Niezabitowska, Karolina, additional, Woźnica, Katarzyna, additional, Grodzicki, Tomasz, additional, Małecki, Maciej, additional, Bociąga-Jasik, Monika, additional, Rajzer, Marek, additional, Sładek, Krzysztof, additional, Wizner, Barbara, additional, Biecek, Przemysław, additional, and Krzanowski, Marcin, additional

Published
2024
Full Text
View/download PDF

10. Serial echocardiographic evaluation of COVID-19 patients without prior history of structural heart disease: a 1-year follow-up CRACoV-HHS study

Author

Olszanecka, Agnieszka, primary, Wojciechowska, Wiktoria, additional, Bednarek, Agnieszka, additional, Kusak, Piotr, additional, Wizner, Barbara, additional, Terlecki, Michał, additional, Stolarz-Skrzypek, Katarzyna, additional, Klocek, Marek, additional, Drożdż, Tomasz, additional, Sładek, Krzysztof, additional, Bociąga-Jasik, Monika, additional, Garlicki, Aleksander, additional, Rewiuk, Krzysztof, additional, Matyja, Andrzej, additional, Małecki, Maciej, additional, Sydor, Wojciech, additional, Krzanowski, Marcin, additional, Grodzicki, Tomasz, additional, and Rajzer, Marek, additional

Published
2023
Full Text
View/download PDF

13. Risk factors of acute kidney injury during hospitalization in acute ischaemic stroke patients undergoing mechanical thrombectomy.

Author

Wrona, Paweł, Sawczyńska, Katarzyna, Wróbel, Dominik, Zdrojewska, Kaja, Giełczyński, Mateusz, Mizera, Paweł, Brzegowy, Paweł, Popiela, Tadeusz, Słowik, Agnieszka, and Krzanowski, Marcin

Subjects
ACUTE kidney failure, ISCHEMIC stroke, STROKE patients, THROMBOLYTIC therapy, THROMBECTOMY, CHRONIC kidney failure, HYPERKALEMIA
Abstract

Introduction: Acute kidney injury (AKI) seems to worsen the prognosis of acute ischaemic stroke (AIS) patients treated with mechanical thrombectomy (MT). At the same time, the procedure of MT increases AKI risk by iodinated contrast use. Identification of factors predisposing to AKI after MT is important for recognizing vulnerable patients and successful prevention. Aim: To identify factors associated with the occurrence of AKI during hospitalization in MT-treated AIS patients. Material and methods: The study included all AIS patients treated with MT in the University Hospital in Krakow from 2019 to 2021. The diagnosis of AKI during hospitalisation was based on serum creatinine concentration levels, according to the Kidney Disease Improving Global Outcomes guidelines. We compared patients with and without AKI in terms of age, sex, comorbidities, stroke course and laboratory test results at admission. We identified factors associated with the occurrence of AKI using univariate logistic regression analysis, with significant variables subsequently added to the multivariate analyses. Results: Among 593 MT-treated AIS patients the incidence of AKI during hospitalisation was 12.6%. AKI development was associated with diabetes, chronic kidney disease, total volume of iodinated contrast obtained during hospitalisation, posterior circulation stroke, lack of intravenous thrombolysis, and laboratory test results at admission: haemoglobin, glucose, urea, potassium, and creatinine. Total contrast volume and urea level were the most important independent risk factors associated with occurrence of AKI. Conclusions: AKI is common in MT-treated AIS patients. There is a need to establish a protocol for decreasing the risk of AKI in AIS patients undergoing MT and, in case it occurs, a procedure for its treatment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment

Author

Banaszkiewicz, Małgorzata, primary, Małyszko, Jolanta, additional, Batko, Krzysztof, additional, Koc-Żórawska, Ewa, additional, Żórawski, Marcin, additional, Dumnicka, Paulina, additional, Jurczyszyn, Artur, additional, Woziwodzka, Karolina, additional, Maleszka, Aleksandra, additional, Krzanowski, Marcin, additional, Kraśniak, Andrzej, additional, Drożdż, Ryszard, additional, and Krzanowska, Katarzyna, additional

Published
2022
Full Text
View/download PDF

18. Zonulin-related peptides in the setting of multiple myeloma - evaluation of a candidate molecule with respect to anemia, chronic kidney disease, and tumor burden: a pilot study

Author

Banaszkiewicz, Małgorzata, Małyszko, Jolanta, Woziwodzka, Karolina, Koc-Żórawska, Ewa, Dumnicka, Paulina, Jurczyszyn, Artur, Batko, Krzysztof, Gołasa, Paulina, Maleszka, Aleksandra, Krzanowski, Marcin, Żórawski, Marcin, Małyszko, Jacek, Drożdż, Ryszard, Kuźniewski, Marek, and Krzanowska, Katarzyna

Published
2022

19. Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?

Author

Woziwodzka, Karolina, primary, Małyszko, Jolanta, additional, Koc-Żórawska, Ewa, additional, Żórawski, Marcin, additional, Dumnicka, Paulina, additional, Jurczyszyn, Artur, additional, Batko, Krzysztof, additional, Mazur, Paulina, additional, Banaszkiewicz, Małgorzata, additional, Krzanowski, Marcin, additional, Gołasa, Paulina, additional, Małyszko, Jacek A., additional, Drożdż, Ryszard, additional, and Krzanowska, Katarzyna, additional

Published
2021
Full Text
View/download PDF

20. Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients

Author

Woziwodzka, Karolina, primary, Małyszko, Jolanta, additional, Koc-Żórawska, Ewa, additional, Żórawski, Marcin, additional, Dumnicka, Paulina, additional, Jurczyszyn, Artur, additional, Batko, Krzysztof, additional, Mazur, Paulina, additional, Banaszkiewicz, Małgorzata, additional, Krzanowski, Marcin, additional, Gołasa, Paulina, additional, Małyszko, Jacek A., additional, Drożdż, Ryszard, additional, and Krzanowska, Katarzyna, additional

Published
2021
Full Text
View/download PDF

21. Mortality Following Infection in Europe: A Retrospective Multicenter Case-Control Study

Author

Czepiel, Jacek, Krutova, Marcela, Mizrahi, Assaf, Khanafer, Nagham, Enoch, David A, Patyi, Márta, Deptuła, Aleksander, Agodi, Antonella, Nuvials, Xavier, Pituch, Hanna, Wójcik-Bugajska, Małgorzata, Filipczak-Bryniarska, Iwona, Brzozowski, Bartosz, Krzanowski, Marcin, Konturek, Katarzyna, Fedewicz, Marcin, Michalak, Mateusz, Monpierre, Lorra, Vanhems, Philippe, Gouliouris, Theodore, Jurczyszyn, Artur, Goldman-Mazur, Sarah, Wultańska, Dorota, Kuijper, Ed J, Skupień, Jan, Biesiada, Grażyna, and Garlicki, Aleksander

Subjects
genetic structures, Clostridioides difficile infection, co–morbidities, outcome, risk factors, mortality, malignancy
Abstract

We aimed to describe the clinical presentation, treatment, outcome and report on factors associated with mortality over a 90-day period in Clostridioides difficile infection (CDI). Descriptive, univariate, and multivariate regression analyses were performed on data collected in a retrospective case-control study conducted in nine hospitals from seven European countries. A total of 624 patients were included, of which 415 were deceased (cases) and 209 were still alive 90 days after a CDI diagnosis (controls). The most common antibiotics used previously in both groups were β-lactams; previous exposure to fluoroquinolones was significantly (p = 0.0004) greater in deceased patients. Multivariate logistic regression showed that the factors independently related with death during CDI were older age, inadequate CDI therapy, cachexia, malignancy, Charlson Index, long-term care, elevated white blood cell count (WBC), C-reactive protein (CRP), bacteraemia, complications, and cognitive impairment. In addition, older age, higher levels of WBC, neutrophil, CRP or creatinine, the presence of malignancy, cognitive impairment, and complications were strongly correlated with shortening the time from CDI diagnosis to death. CDI prevention should be primarily focused on hospitalised elderly people receiving antibiotics. WBC, neutrophil count, CRP, creatinine, albumin and lactate levels should be tested in every hospitalised patient treated for CDI to assess the risk of a fatal outcome.

Published
2021

22. Mortality following Clostridioides difficile infection in Europe

Author

Czepiel, Jacek, Krutova, Marcela, Mizrahi, Assaf, Khanafer, Nagham, Enoch, David A., Patyi, Márta, Deptuła, Aleksander, Agodi, Antonella, Nuvials, Xavier, Pituch, Hanna, Wójcik-Bugajska, Małgorzata, Filipczak-Bryniarska, Iwona, Brzozowski, Bartosz, Krzanowski, Marcin, Konturek, Katarzyna, Fedewicz, Marcin, Michalak, Mateusz, Monpierre, Lorra, Vanhems, Philippe, Gouliouris, Theodore, Jurczyszyn, Artur, Goldman-Mazur, Sarah, Wultańska, Dorota, Kuijper, Ed J., Skupień, Jan, Biesiada, Grażyna, Garlicki, Aleksander, Universitat Autònoma de Barcelona, Uniwersytet Jagielloński w Krakowie = Jagiellonian University (UJ), Charles University [Prague] (CU), ESCMID Study Group for Clostridioides Difficile (ESGCD), MICrobiologie de l'ALImentation au Service de la Santé (MICALIS), AgroParisTech-Université Paris-Saclay-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Groupe Hospitalier Paris Saint-Joseph (hpsj), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospices Civils de Lyon (HCL), Addenbrooke's Hospital, Cambridge University NHS Trust, Bács-Kiskun County Teaching Hospital, Nicolaus Copernicus University [Toruń], University of Catania [Italy], Vall d'Hebron University Hospital [Barcelona], Medical University of Warsaw - Poland, University Hospital of Cracow/Szpital Uniwersytecki w Krakowie [Poland] (SUK), Józef Babinski Hospital, Ludwik Rydygier Hospital, Leiden University Medical Center (LUMC), Universiteit Leiden, Rijksinstituut voor Volksgezondheid en Milieu (RIVM), Institut Català de la Salut, [Czepiel J] Department of Infectious and Tropical Diseases, Jagiellonian University Medical College, Krakow, Poland. [Krutova M] Department of Medical Microbiology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic. ESCMID Study Group for Clostridioides Difficile (ESGCD), Basel, Switzerland. [Mizrahi A] ESCMID Study Group for Clostridioides Difficile (ESGCD), Basel, Switzerland. Service de Microbiologie Clinique, Groupe Hospitalier Paris Saint-Joseph, Paris, France. Institut Micalis UMR 1319, Université Paris-Saclay, INRAe, AgroParisTech, Châtenay Malabry, France. [Khanafer N] ESCMID Study Group for Clostridioides Difficile (ESGCD), Basel, Switzerland. Unité d’Hygiène, Epidémiologie et Prévention, Groupement Hospitalier Centre, Hospices Civils de Lyon, Lyon, France. Centre International de Recherche en Infectiologie (CIRI), Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID), Université de Lyon, Lyon, France. [Enoch DA] Clinical Microbiology & Public Health Laboratory, Public Health England, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0QQ, UK. [Patyi M] Hygienic Department, Bács-Kiskun County Teaching Hospital, Bács-Kiskun, Hungary. [Nuvials X] Servei de Medicina Intensiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de recerca SODIR, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus, Centre International de Recherche en Infectiologie - UMR (CIRI), École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), and Casal, Bérengère

Subjects
0301 basic medicine, genetic structures, Clostridioides difficile infection, [SDV]Life Sciences [q-bio], Antibiotics, técnicas de investigación::métodos epidemiológicos::características de los estudios epidemiológicos::estudios epidemiológicos::estudios de casos y controles [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Logistic regression, Biochemistry, chemistry.chemical_compound, 0302 clinical medicine, Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections::Clostridium Infections [DISEASES], risk factors, Pharmacology (medical), 030212 general & internal medicine, Co-morbidities, General Pharmacology, Toxicology and Pharmaceutics, Outcome, Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics::Epidemiologic Studies::Case-Control Studies [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Clostridi - Europa, [SDV] Life Sciences [q-bio], Infectious Diseases, Absolute neutrophil count, outcome, localizaciones geográficas::Europa (continente) [DENOMINACIONES GEOGRÁFICAS], Microbiology (medical), medicine.medical_specialty, infecciones bacterianas y micosis::infecciones bacterianas::infecciones por bacterias grampositivas::infecciones por Clostridium [ENFERMEDADES], medicine.drug_class, 030106 microbiology, Malignancy, Geographic Locations::Europe [GEOGRAPHICALS], Microbiology, Cachexia, 03 medical and health sciences, Internal medicine, Other subheadings::Other subheadings::Other subheadings::/mortality [Other subheadings], medicine, Mortality, Creatinine, Clostridioides Clostridioides difficile infection, Otros calificadores::Otros calificadores::Otros calificadores::/mortalidad [Otros calificadores], business.industry, lcsh:RM1-950, Case-control study, medicine.disease, mortality, co-morbidities, lcsh:Therapeutics. Pharmacology, chemistry, Risk factors, co–morbidities, Malalties bacterianes - Estudi de casos, business, Clostridioides, malignancy
Abstract

We aimed to describe the clinical presentation, treatment, outcome and report on factors associated with mortality over a 90-day period in Clostridioides difficile infection (CDI). Descriptive, univariate, and multivariate regression analyses were performed on data collected in a retrospective case-control study conducted in nine hospitals from seven European countries. A total of 624 patients were included, of which 415 were deceased (cases) and 209 were still alive 90 days after a CDI diagnosis (controls). The most common antibiotics used previously in both groups were β-lactams, previous exposure to fluoroquinolones was significantly (p = 0.0004) greater in deceased patients. Multivariate logistic regression showed that the factors independently related with death during CDI were older age, inadequate CDI therapy, cachexia, malignancy, Charlson Index, long-term care, elevated white blood cell count (WBC), C-reactive protein (CRP), bacteraemia, complications, and cognitive impairment. In addition, older age, higher levels of WBC, neutrophil, CRP or creatinine, the presence of malignancy, cognitive impairment, and complications were strongly correlated with shortening the time from CDI diagnosis to death. CDI prevention should be primarily focused on hospitalised elderly people receiving antibiotics. WBC, neutrophil count, CRP, creatinine, albumin and lactate levels should be tested in every hospitalised patient treated for CDI to assess the risk of a fatal outcome.

Published
2021
Full Text
View/download PDF

25. CRACoV-HHS : an interdisciplinary project for multi-specialist hospital and non-hospital care for patients with SARS-CoV-2 infection as well hospital staff assessment for infection exposure

Author

Sydor, Wojciech, Wizner, Barbara, Strach, Magdalena, Bociąga-Jasik, Monika, Mytel, Krzysztof, Olszanecka, Agnieszka, Sanak, Marek, Małecki, Maciej, Wójkowska-Mach, Jadwiga, Chrzan, Robert, Garlicki, Aleksander, Gosiewski, Tomasz, Krzanowski, Marcin, Surowiec, Jarosław, Bednarz, Stefan, Jędrychowski, Marcin, and Grodzicki, Tomasz

Published
2021

26. Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland

Author

Terlecki, Michał, primary, Wojciechowska, Wiktoria, additional, Klocek, Marek, additional, Olszanecka, Agnieszka, additional, Stolarz-Skrzypek, Katarzyna, additional, Grodzicki, Tomasz, additional, Małecki, Maciej, additional, Katra, Barbara, additional, Garlicki, Aleksander, additional, Bociąga-Jasik, Monika, additional, Sładek, Krzysztof, additional, Matyja, Andrzej, additional, Wordliczek, Jerzy, additional, Słowik, Agnieszka, additional, Mach, Tomasz, additional, Krzanowska, Katarzyna, additional, Krzanowski, Marcin, additional, Stręk, Paweł, additional, Chłosta, Piotr, additional, Hydzik, Piotr, additional, Korkosz, Mariusz, additional, Popiela, Tadeusz, additional, Pilecki, Maciej, additional, Gądek, Artur, additional, and Rajzer, Marek, additional

Published
2021
Full Text
View/download PDF

27. Impact of Arterial Hypertension and Use of Antihypertensive Pharmacotherapy on Mortality in Patients Hospitalized due to COVID-19: The CRACoV-HHS Study.

Author

Wojciechowska, Wiktoria, Terlecki, Michał, Klocek, Marek, Pac, Agnieszka, Olszanecka, Agnieszka, Stolarz-Skrzypek, Katarzyna, Jastrzębski, Marek, Jankowski, Piotr, Ostrowska, Aleksandra, Drożdż, Tomasz, Prejbisz, Aleksander, Dobrowolski, Piotr, Januszewicz, Andrzej, Krzanowski, Marcin, Małecki, Maciej T., Grodzicki, Tomasz, Kreutz, Reinhold, Rajzer, Marek, and CRACoV-HHS Investigators†

Abstract

Background: Cardiovascular diseases including arterial hypertension are common comorbidities among patients hospitalized due to COVID-19. We assessed the influence of preexisting hypertension and its pharmacological treatment on in-hospital mortality in patients hospitalized with COVID-19.Methods: We studied all consecutive patients who were admitted to the University Hospital in Krakow, Poland, due to COVID-19 between March 2020 and May 2021. Data of 5191 patients (mean age 61.9±16.7 years, 45.2% female) were analyzed.Results: The median hospitalization time was 14 days, and the mortality rate was 18.4%. About a quarter of patients had an established cardiovascular disease including coronary artery disease (16.6%) or stroke (7.6%). Patients with hypertension (58.3%) were older and had more comorbidities than patients without hypertension. In multivariable logistic regression analysis, age above median (64 years), male gender, history of heart failure or chronic kidney disease, and higher C-reactive protein level, but not preexisting hypertension, were independent risk factors for in-hospital death in the whole study group. Patients with hypertension already treated (n=1723) with any first-line antihypertensive drug (angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, calcium channel blockers, or thiazide/thiazide-like diuretics) had a significantly lower risk of in-hospital death (odds ratio, 0.25 [95% CI, 0.2-0.3]; P<0.001) compared to nontreated hypertensives (n=1305).Conclusions: Although the diagnosis of preexisting hypertension per se had no significant impact on in-hospital mortality among patients with COVID-19, treatment with any first-line blood pressure-lowering drug had a profound beneficial effect on survival in patients with hypertension. These data support the need for antihypertensive pharmacological treatment during the COVID-19 pandemic. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

29. MO128RETINOL BINDING PROTEIN (RBP) - NEW BIOMARKER OF KIDNEY INJURY IN MULTIPLE MYELOMA PATIENTS*

Author

Woziwodzka, Karolina, primary, Malyszko, Jolanta, additional, Banaszkiewicz, Małgorzata, additional, Koc- Żorawska, Ewa, additional, Dumnicka, Paulina, additional, Jurczyszyn, Artur, additional, Batko, Krzysztof, additional, Tisończyk, Joanna, additional, Gołasa, Paulina, additional, Krzanowski, Marcin, additional, Zorawski, Marcin, additional, Małyszko, Jacek, additional, Drozdz, Ryszard, additional, and Krzanowska, Katarzyna, additional

Published
2021
Full Text
View/download PDF

31. Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma

Author

Banaszkiewicz, Małgorzata, primary, Małyszko, Jolanta, additional, Batko, Krzysztof, additional, Koc-Żórawska, Ewa, additional, Żórawski, Marcin, additional, Dumnicka, Paulina, additional, Jurczyszyn, Artur, additional, Woziwodzka, Karolina, additional, Tisończyk, Joanna, additional, Krzanowski, Marcin, additional, Małyszko, Jacek, additional, Waszczuk-Gajda, Anna, additional, Drożdż, Ryszard, additional, Kuźniewski, Marek, additional, and Krzanowska, Katarzyna, additional

Published
2020
Full Text
View/download PDF

35. P0745URINE TIMP-2 AND IGFBP-7- NEW BIOMARKERS OF KIDNEY INJURY IN MULTIPLE MYELOMA PATIENTS

Author

Woziwodzka, Karolina, primary, Malyszko, Jolanta, primary, Banaszkiewicz, Małgorzata, primary, Koc- Żorawska, Ewa, primary, Dumnicka, Paulina, primary, Jurczyszyn, Artur, primary, Batko, Krzysztof, primary, Mazur, Paulina, primary, Krzanowski, Marcin, primary, Zorawski, Marcin, primary, Małyszko, Jacek, primary, Drozdz, Ryszard, primary, Kuznieswki, Marek Jan, primary, and Krzanowska, Katarzyna, primary

Published
2020
Full Text
View/download PDF

36. P0712TRANSGELIN AS A POTENTIAL MARKER OF RENAL IMPAIRMENT IN MULTIPLE MYELOMA PATIENTS

Author

Woziwodzka, Karolina, primary, Malyszko, Jolanta, primary, Banaszkiewicz, Małgorzata, primary, Koc- Żorawska, Ewa, primary, Dumnicka, Paulina, primary, Jurczyszyn, Artur, primary, Batko, Krzysztof, primary, Maleszka, Aleksandra, primary, Krzanowski, Marcin, primary, Miarka, P, primary, Zorawski, Marcin, primary, Małyszko, Jacek, primary, Drozdz, Ryszard, primary, Kuznieswki, Marek Jan, primary, and Krzanowska, Katarzyna, primary

Published
2020
Full Text
View/download PDF

37. P0868ZONULIN AS A THERAPEUTIC POTENTIAL BIOMARKER OF ANEMIA IN PATIENTS WITH MULTIPLE MYELOMA AND CHRONIC KIDNEY DISEASE

Author

Woziwodzka, Karolina, primary, Malyszko, Jolanta, primary, Banaszkiewicz, Małgorzata, primary, Koc- Żorawska, Ewa, primary, Dumnicka, Paulina, primary, Krzanowski, Marcin, primary, Batko, Krzysztof, primary, Gołasa, Paulina, primary, Tisonczyk, Joanna, primary, Zorawski, Marcin, primary, Małyszko, Jacek, primary, Drozdz, Ryszard, primary, Kuznieswki, Marek Jan, primary, and Krzanowska, Katarzyna, primary

Published
2020
Full Text
View/download PDF

38. New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies

Author

Woziwodzka, Karolina, primary, Vesole, David H., additional, Małyszko, Jolanta, additional, Batko, Krzysztof, additional, Jurczyszyn, Artur, additional, Koc-Żórawska, Ewa, additional, Krzanowski, Marcin, additional, Małyszko, Jacek, additional, Żórawski, Marcin, additional, Waszczuk-Gajda, Anna, additional, Kuźniewski, Marek, additional, and Krzanowska, Katarzyna, additional

Published
2020
Full Text
View/download PDF

42. SP354Hepcidin 25, anaemia parameters and kidney failure – are they connected in multiple myeloma patients?

Author

Zorawski Marcin, Mazur Paulina, Małyszko Jacek, Woziwodzka Karolina, Krzanowska Katarzyna, Koc-Zorawska Ewa, Maleszka Aleksandra, Drożdż Ryszard, Banaszkiewicz Małgorzata, Jurczyszyn Artur, Kuzniewski Marek, Małyszko Jolanta, Krzanowski Marcin, and Dumnicka Paulina

Subjects
Transplantation, Kidney, medicine.medical_specialty, biology, business.industry, Anemia, medicine.disease, Gastroenterology, medicine.anatomical_structure, Nephrology, Hepcidin, Internal medicine, medicine, biology.protein, business, Multiple myeloma
Published
2019
Full Text
View/download PDF

43. FP147GDF-15, inflammation, malnutrition and anaemia in multiple myeloma depending on stage of kidney failure

Author

Małyszko Jolanta, Banaszkiewicz Małgorzata, Małyszko Jacek, Mazur Paulina, Cieniawski Dominik, Drożdż Ryszard, Kuzniewski Marek, Koc-Zorawska Ewa, Krzanowski Marcin, Dumnicka Paulina, Woziwodzka Karolina, Zorawski Marcin, Jurczyszyn Artur, and Krzanowska Katarzyna

Subjects
Transplantation, Kidney, medicine.medical_specialty, business.industry, Inflammation, medicine.disease, Gastroenterology, Malnutrition, medicine.anatomical_structure, Nephrology, Internal medicine, Medicine, medicine.symptom, Stage (cooking), business, Multiple myeloma
Published
2019
Full Text
View/download PDF

44. FP368Periostin - a potential marker of tubulointerstitial renal impairment in multiple myeloma patients

Author

Małyszko Jacek, Suska Anna, Drożdż Ryszard, Kuzniewski Marek, Jurczyszyn Artur, Krzanowska Katarzyna, Maleszka Aleksandra, Koc-Zorawska Ewa, Woziwodzka Karolina, Małyszko Jolanta, Dumnicka Paulina, Zorawski Marcin, Miarka Przemyslaw, Banaszkiewicz Małgorzata, and Krzanowski Marcin

Subjects
Oncology, Transplantation, medicine.medical_specialty, Nephrology, business.industry, Internal medicine, medicine, business, medicine.disease, Multiple myeloma
Published
2019
Full Text
View/download PDF

45. SP351Relation between sTfR, blood cell counts, inflammatory markers, malnutrition markers, iron status and kidney failure in multiple myeloma

Author

Suska Anna, Małyszko Jacek, Maleszka Aleksandra, Dumnicka Paulina, Drożdż Ryszard, Koc-Zorawska Ewa, Banaszkiewicz Małgorzata, Krzanowska Katarzyna, Małyszko Jolanta, Woziwodzka Karolina, Zorawski Marcin, Krzanowski Marcin, Jurczyszyn Artur, and Kuzniewski Marek

Subjects
Transplantation, medicine.medical_specialty, Kidney, business.industry, medicine.disease, Gastroenterology, Blood cell, Malnutrition, medicine.anatomical_structure, Nephrology, Internal medicine, medicine, Iron status, business, Multiple myeloma
Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results